Eanna Fennell receives funding from the Irish Research Council and Horizon Europe. Over 95% of the world’s adult population is infected with Epstein–Barr virus (EBV), but most people never realise it.

The Mega Millions jackpot continues to rise for the Feb. 20 drawing, now reaching $416 million with a cash value of $193.1 million. If someone were to get lucky tonight and win the jackpot, they’ll ...

Shopping for prescription glasses online is easier than ever, which is great news for anyone who knows how time-consuming and expensive the process can be. We considered nearly a dozen eyewear ...

Ashley is a lead editor of mortgages and loans at Forbes Advisor. She graduated from Utah Tech University with a bachelor’s in English with an emphasis in creative writing. She began her career ...

Demyelination is damage to myelin, the fatty coating that protects nerves and speeds signals. When myelin breaks down, nerve messages slow and axons can deteriorate. Symptoms depend on where myelin is ...

In the United States, multiple sclerosis (MS) is considered a disability, so you may qualify for government housing help. Options include public housing, rent vouchers, and homeownership vouchers if ...

Multiple sclerosis (MS) is a chronic, disabling, inflammatory disease that damages your nerves. People with MS typically live roughly seven years less than the general population, with an average life ...

Investors seeking safety from inflation flock to 20- and 30-year Treasury bonds; yields fall by 10 basis points each to around 3.5% and 3.3%, respectively ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Data on investigational obexelimab and frexalimab, blood neurofilament light chain as a marker for treatment response, and benefits of ofatumumab in subgroups are highlights in RRMS from ACTRIMS 2026.